75 (PB065) - Biochemical characterization of TNG908 as a novel, potent MTA-cooperative PRMT5 inhibitor for the treatment of MTAP-deleted cancers

Autor: Zhang, W., Gong, S., Cottrell, K., Briggs, K., Tonini, M., Gu, L., Whittington, D., Yuan, H., Gotur, D., Jahic, H., Huang, A., Maxwell, J., Mallender, W.
Zdroj: In European Journal of Cancer October 2022 174 Supplement 1:S26-S26
Databáze: ScienceDirect
Externí odkaz: